N. Tsopelas

发表

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.

S. DeKosky, W. Klunk, J. Price, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Frequent amyloid deposition without significant cognitive impairment among the elderly.

Jeffrey A. James, S. DeKosky, P. Houck, 2008, Archives of neurology.

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

S. DeKosky, W. Klunk, C. Mathis, 2008, Brain : a journal of neurology.

Development and Application of b-Amyloid Imaging Agents in Alzheimer’s Disease

S. DeKosky, W. Klunk, C. Mathis, 2016 .

Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients.

Patrick R Hof, Cheuk Y. Tang, Philip D. Harvey, 2008, The American journal of psychiatry.

Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy

Philip D. Harvey, K. Davis, W. Tsai, 2011, Neuropsychopharmacology.

Relationships between white matter metabolite abnormalities, cognitive and social functioning in elderly schizophrenic subjects

K. Davis, J. Friedman, Linda Chang, 2008, Schizophrenia Research.

P2-366 Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees

Keith A. Johnson, D. Pollen, A. Fischman, 2006, Alzheimer's & Dementia.

The relationship of psychiatric illnesses and seizures

G. Fricchione, N. Tsopelas, R. Saintfort, 2001, Current psychiatry reports.

32 – Cholinergic Treatments of Alzheimer's Disease

D. Marin, N. Tsopelas, 2001 .

Amyloid Imaging with PET in Alzheimer’s Disease, Mild Cognitive Impairment, and Clinically Unimpaired Subjects

S. DeKosky, W. Klunk, C. Mathis, 2009 .

Brain Metabolite Abnormalities in the White Matter of Elderly Schizophrenic Subjects: Implication for Glial Dysfunction

Linda Chang, Thomas Ernst, K. Davis, 2007, Biological Psychiatry.

Imaging Alzheimer Pathology in Late-Life Depression With PET and Pittsburgh Compound-B

C. Reynolds, S. DeKosky, W. Klunk, 2008, Alzheimer disease and associated disorders.

Chronic High-Fat Diet Drives Postnatal Epigenetic Regulation of μ-Opioid Receptor in the Brain

Philip D. Harvey, K. Davis, W. Tsai, 2011, Neuropsychopharmacology.

Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B

James T. Becker, William E. Klunk, Chester A. Mathis, 2008, Journal of Neuroscience Methods.

Identifying Intimate Partner Violence (IPV) during the postpartum period in a Greek sample

N. Tsopelas, C. Lionis, J. Brown, 2010, Archives of Women's Mental Health.

Estrogens and Alzheimer's Disease

D. Marin, N. Tsopelas, 2001 .

Validation of the Greek Maternal Adjustment and Maternal Attitudes Scale for Assessing Early Postpartum Adjustment

N. Tsopelas, C. Lionis, D. Bick, 2012, Women & health.

Anti-N-Methyl-D-Aspartate ( Anti-NMDA ) Receptor Encephalitis as the Initial Presentation of Small Cell Carcinoma of the Lung in a Middle-Aged Man

N. Tsopelas, C. Aggarwal, C. McGrath, 2016 .

Human amyloid-imaging studies with Pittsburgh Compound-B in mild cognitive impairment (MCI): Is MCI the critical period of amyloid plaque deposition?

S. DeKosky, W. Klunk, C. Mathis, 2005, Alzheimer's & Dementia.

Frequent amyloid deposition without significant cognitive impairment among the elderly.

Jeffrey A. James, S. DeKosky, P. Houck, 2008, Archives of neurology.

Midwifery empathy scale: development and validation for a greek sample

N. Tsopelas, E. Patelarou, Anastasia Charitou, 2016 .

Maternal screening for early postnatal vulnerability.

N. Tsopelas, A. Vgontzas, E. Petridou, 2016, Psychiatrike = Psychiatriki.

IC–103–05: Pittsburgh compound–B four years later: What have we learned, what lies ahead?

William E. Klunk, Chester A. Mathis, Julie C. Price, 2006 .